Search
AN2 Therapeutics Inc
ANTXAdd to Watchlist
4.420USD
-0.280-5.96%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
159.19MMarket Cap
LossP/E TTM
AN2 Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-1.16
32.34%
Analyst Rating
STRONG BUY
2026-07-02
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of AN2 Therapeutics Inc?
According to AN2 Therapeutics Inc's FY2025 earnings report, its current assets were 59.94M, with a year-on-year change of -30.52.
What are the total assets of AN2 Therapeutics Inc?
According to AN2 Therapeutics Inc's FY2025 earnings report, its total assets of AN2 Therapeutics Inc were 61.95M, with a year-on-year change of -32.73.
What are the total liabilities of AN2 Therapeutics Inc?
According to AN2 Therapeutics Inc's FY2025 earnings report, its total liabilities of AN2 Therapeutics Inc were 8.89M, with a year-on-year change of -13.17.
What is the total equity of AN2 Therapeutics Inc?
According to AN2 Therapeutics Inc's FY2025 earnings report, its total equity of AN2 Therapeutics Inc was 53.06M, with a year-on-year change of -35.17.
What is the net investment of AN2 Therapeutics Inc?
According to AN2 Therapeutics Inc's FY2025 earnings report, its net investment of AN2 Therapeutics Inc was 28.31M, with a year-on-year change of -48.14.
What is the net financing of AN2 Therapeutics Inc?
According to AN2 Therapeutics Inc's FY2025 earnings report, its net financing of AN2 Therapeutics Inc was 113.00K, with a year-on-year change of -69.62.
What is the Earnings Per Share (EPS) of AN2 Therapeutics Inc?
According to AN2 Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.16, with a year-on-year change of 32.34.
What is the Return on Equity (ROE) of AN2 Therapeutics Inc?
According to AN2 Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -52.14, with a year-on-year change of -4.93.
What is the Return on Assets (ROA) of AN2 Therapeutics Inc?
According to AN2 Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -45.67, with a year-on-year change of -2.71.
What is the operating profit of AN2 Therapeutics Inc?
According to AN2 Therapeutics Inc's FY2025 earnings report, its operating profit was -38.11M, with a year-on-year change of 30.14.